165 related articles for article (PubMed ID: 12377786)
1. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.
Duez H; Chao YS; Hernandez M; Torpier G; Poulain P; Mundt S; Mallat Z; Teissier E; Burton CA; Tedgui A; Fruchart JC; Fiévet C; Wright SD; Staels B
J Biol Chem; 2002 Dec; 277(50):48051-7. PubMed ID: 12377786
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
[TBL] [Abstract][Full Text] [Related]
4. [Differential expressions of lipid metabolism related genes in the liver of young apoE knockout mice].
Ye HY; Yin M; Shang YJ; Dai XD; Zhang SQ; Jing W; Du HQ; Zhang L; Pan J
Sheng Li Xue Bao; 2008 Feb; 60(1):51-8. PubMed ID: 18288358
[TBL] [Abstract][Full Text] [Related]
5. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
6. Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice.
Shi ST; Li YF; Guo YQ; Wang ZH
J Cardiovasc Pharmacol; 2014 Nov; 64(5):407-11. PubMed ID: 24979391
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E.
Fu T; Kashireddy P; Borensztajn J
Biochem J; 2003 Aug; 373(Pt 3):941-7. PubMed ID: 12713444
[TBL] [Abstract][Full Text] [Related]
8. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.
Peters JM; Hennuyer N; Staels B; Fruchart JC; Fievet C; Gonzalez FJ; Auwerx J
J Biol Chem; 1997 Oct; 272(43):27307-12. PubMed ID: 9341179
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.
Vu-Dac N; Schoonjans K; Laine B; Fruchart JC; Auwerx J; Staels B
J Biol Chem; 1994 Dec; 269(49):31012-8. PubMed ID: 7983038
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice.
Declercq V; Yeganeh B; Moshtaghi-Kashanian GR; Khademi H; Bahadori B; Moghadasian MH
J Cardiovasc Pharmacol; 2005 Jul; 46(1):18-24. PubMed ID: 15965350
[TBL] [Abstract][Full Text] [Related]
11. NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha.
Morishima A; Ohkubo N; Maeda N; Miki T; Mitsuda N
J Biol Chem; 2003 Oct; 278(40):38188-93. PubMed ID: 12882972
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol.
Kooistra T; Verschuren L; de Vries-van der Weij J; Koenig W; Toet K; Princen HM; Kleemann R
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2322-30. PubMed ID: 16873727
[TBL] [Abstract][Full Text] [Related]
14. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
[TBL] [Abstract][Full Text] [Related]
15. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.
Vu-Dac N; Chopin-Delannoy S; Gervois P; Bonnelye E; Martin G; Fruchart JC; Laudet V; Staels B
J Biol Chem; 1998 Oct; 273(40):25713-20. PubMed ID: 9748239
[TBL] [Abstract][Full Text] [Related]
16. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.
Srivastava RA
Mol Cell Biochem; 2000 Jun; 209(1-2):125-9. PubMed ID: 10942210
[TBL] [Abstract][Full Text] [Related]
18. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-V modulates multiple atherogenic mechanisms in a mouse model of disturbed clearance of triglyceride-rich lipoproteins.
Grosskopf I; Shaish A; Afek A; Shemesh S; Harats D; Kamari Y
Atherosclerosis; 2012 Sep; 224(1):75-83. PubMed ID: 22809445
[TBL] [Abstract][Full Text] [Related]
20. Comparative effect of fenofibrate on hepatic desaturases in wild-type and peroxisome proliferator-activated receptor alpha-deficient mice.
Guillou H; Martin P; Jan S; D'Andrea S; Roulet A; Catheline D; Rioux V; Pineau T; Legrand P
Lipids; 2002 Oct; 37(10):981-9. PubMed ID: 12530558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
